In ccRCC samples, the 5 genes with the highest mutation rates were VHL (47%), PBRM1 (40%), TTN (14%), SETD2 (12%) and BAP1 (10%) (Fig. 1B). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.